AnalystsVikram PurohitVikram Purohit's Stock Forecasts
AnalystsVikram Purohit
Analyst Ranking
Bottom 7%
#4282 out of 4563 analysts
Average Return
-27.22%
Win Rate
13%6 out of 48
Risk vs Reward
Poor
Good
Vikram Purohit's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pandion Therapeutics IncPAND | +219.36% | $18.85 | $60.20 | 2020-08-10 - 2021-02-26 | Strong Buy |
Incyte CorpINCY | +29.36% | $74.18 | $95.96 | 2020-03-31 - 2020-04-29 | Strong Buy |
Halozyme Therapeutics IncHALO | +13.42% | $34.49 | $39.12 | 2023-05-09 - 2024-04-24 | Strong Buy |
Regenxbio IncRGNX | +7.33% | $22.93 | $24.61 | 2023-03-05 - 2024-03-05 | Strong Buy |
Halozyme Therapeutics IncHALO | +4.68% | $37.37 | $39.12 | 2023-12-25 - 2024-04-24 | Strong Buy |
Vikram Purohit Analyst Color
Get additional color on Vikram Purohit's coverage of popular stocks
Vikram Purohit's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exscientia PLCEXAI | 16 | Hold | $7.00 | +69.49% | Maintains | 3 days ago |
Ascendis Pharma AASND | 17 | Hold | $116.00 | -18.98% | Maintains | 3 days ago |
Abivax SaABVX | 2 | Hold | $16.00 | +0.69% | Maintains | 14 days ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $30.00 | +270.37% | Initiates Coverage On | 24 days ago |
Sage Therapeutics IncSAGE | 6 | Hold | $22.00 | +57.14% | Maintains | 2 months ago |
Halozyme Therapeutics IncHALO | 5 | Strong Buy | $59.00 | +50.82% | Maintains | 4 months ago |
Acelyrin IncSLRN | 6 | Hold | $13.00 | +184.46% | Maintains | 5 months ago |
Foghorn Therapeutics IncFHTX | 7 | Hold | $6.00 | +15.16% | Maintains | 5 months ago |
Ventyx Biosciences IncVTYX | 1 | Hold | $6.00 | +41.51% | Downgrades | 6 months ago |
Incyte CorpINCY | 13 | Hold | $64.00 | +23.70% | Maintains | 6 months ago |
Regenxbio IncRGNX | 7 | Strong Buy | $42.00 | +161.85% | Maintains | 8 months ago |
Evelo Biosciences IncEVLO | 4 | Hold | $10.00 | +3,054.57% | Maintains | 9 months ago |
Recursion Pharmaceuticals IncRXRX | 1 | Hold | $11.00 | +38.54% | Maintains | 9 months ago |
Axsome Therapeutics IncAXSM | 15 | Hold | $90.00 | +26.46% | Maintains | 10 months ago |
Hookipa Pharma IncHOOK | 3 | Hold | $2.25 | +164.71% | Maintains | a year ago |
Arcutis Biotherapeutics IncARQT | 5 | Strong Buy | $50.00 | N/A | Maintains | a year ago |
Tourmaline Bio IncTRML | 5 | Hold | $3.00 | N/A | Maintains | a year ago |
Akili IncAKLI | 2 | Hold | $3.00 | N/A | Maintains | a year ago |
Kymera Therapeutics IncKYMR | 8 | Hold | $41.00 | N/A | Maintains | a year ago |
Instil Bio IncTIL | 7 | Hold | $40.00 | N/A | Maintains | a year ago |
Prokidney CorpPROK | 1 | Hold | $13.00 | N/A | Initiates Coverage On | a year ago |
Schrodinger IncSDGR | 4 | Hold | $38.00 | N/A | Maintains | a year ago |
Certara IncCERT | 4 | Hold | $20.00 | N/A | Maintains | 2 years ago |
Theravance Biopharma IncTBPH | 6 | Strong Sell | $10.00 | N/A | Maintains | 2 years ago |
Radius Health IncRDUS1 | 3 | Strong Sell | $7.00 | N/A | Downgrades | 2 years ago |
Tscan Therapeutics IncTCRX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Pandion Therapeutics IncPAND | 2 | Hold | $60.00 | N/A | Downgrades | 3 years ago |
Dbv Technologies SaDBVT | 1 | Hold | $4.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.